LON:RTW RTW Biotech Opportunities (RTW) Share Price, News & Analysis GBX 1.38 0.00 (0.00%) (As of 12/20/2024 11:48 AM ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlines About RTW Biotech Opportunities Stock (LON:RTW) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get RTW alerts:Sign Up Key Stats Today's Range 1.36▼ 1.4150-Day Range 1.38▼ 1.5652-Week Range 1.26▼ 1.73Volume57,164 shsAverage Volume481,267 shsMarket Capitalization£4.63 millionP/E Ratio3.83Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewRTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.Read More… Receive RTW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RTW Biotech Opportunities and its competitors with MarketBeat's FREE daily newsletter. Email Address RTW Stock News HeadlinesSeattle biotech aims to cure hep B with breakthrough gene therapyNovember 13, 2024 | msn.comBiotech industry booms in Eastern Carolina, promoting local job growthOctober 17, 2024 | msn.comWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.December 22, 2024 | Behind the Markets (Ad)Rtw Biotech Regulatory NewsOctober 3, 2024 | lse.co.ukAktis Oncology raises $175m to advance radiopharmaceutical pipelineOctober 1, 2024 | msn.comAKTIS ONCOLOGY ANNOUNCES $175 MILLION OVERSUBSCRIBED SERIES B FINANCING TO FURTHER ADVANCE ITS PROPRIETARY RADIOPHARMACEUTICAL PIPELINESeptember 30, 2024 | finance.yahoo.comCan the billion-dollar bet on biotech finally reverse aging?September 30, 2024 | businessinsider.comRTW Biotech notes BioAge Labs' USD198 million initial public offeringSeptember 27, 2024 | lse.co.ukSee More Headlines RTW Stock Analysis - Frequently Asked Questions How have RTW shares performed this year? RTW Biotech Opportunities' stock was trading at GBX 1.40 at the beginning of the year. Since then, RTW stock has decreased by 1.6% and is now trading at GBX 1.38. View the best growth stocks for 2024 here. How do I buy shares of RTW Biotech Opportunities? Shares of RTW stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. Industry, Sector and Symbol Stock ExchangeLON SectorFinancial Services Industry Asset Management Sub-IndustryN/A Current SymbolLON:RTW CUSIPN/A CIKN/A Webwww.rtwfunds.com Phone646-597-6980FaxN/AEmployees4,971Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 0.36 Trailing P/E Ratio3.83 Forward P/E RatioN/A P/E GrowthN/ANet Income£83.19 million Net Margins1,994.76% Pretax MarginN/A Return on Equity21.42% Return on Assets-0.47% Debt Debt-to-Equity RatioN/A Current Ratio6.35 Quick Ratio0.81 Sales & Book Value Annual Sales£4.17 million Price / Sales1.11 Cash FlowGBX 4.28 per share Price / Cash Flow0.32 Book ValueGBX 190 per share Price / Book0.01Miscellaneous Outstanding Shares335,710,000Free FloatN/AMarket Cap£4.63 million OptionableNot Optionable Beta0.60 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (LON:RTW) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RTW Biotech Opportunities Please log in to your account or sign up in order to add this asset to your watchlist. Share RTW Biotech Opportunities With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
